NVSEF - Novartis AG's (NVS) CEO Vas Narasimhan on Q3 2020 Results - Quick Version Earnings Call Transcript
Novartis AG (NVS) Q3 2020 Earnings Conference Call October 27, 2020 08:50 AM ET Company Participants Samir Shah - Global Head, Investor Relations Vas Narasimhan - Chief Executive Officer Harry Kirsch - Chief Financial Officer Marie-France Tschudin - President, Novartis Pharmaceuticals Susanne Schaffert - President, Novartis Oncology Richard Saynor - Chief Executive Officer, Sandoz John Tsai - Head, Global Drug Development & CMO Conference Call Participants Mark Purcell - Morgan Stanley Graham Parry - Bank of America Andrew Baum - Citi Laura Sutcliffe - UBS Kerry Holford - Berenberg Peter Welford - Jefferies Keyur Parekh - Goldman Sachs Simon Baker - Redburn Florent Cespedes - Societe Generale Richard Vosser - JPMorgan Jo Walton - Credit Suisse Richard Parkes - Exane BNP Presentation Operator [00:00:01] Good morning and good afternoon and welcome to the Novartis Q3 Twenty twenty results release, conference call and live audio webcast. Please note that during the
For further details see:
Novartis AG's (NVS) CEO Vas Narasimhan on Q3 2020 Results - Quick Version Earnings Call Transcript